·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ÇØ¿Ü¾à´ë Ãâ½Å 83¸í, ¾à»ç±¹½Ã º»´Ù...¿¹ºñ½ÃÇè ÇÕ°Ý·ü 46% ±â»çÀÔ·Â : 24.07.04 14:15:02 0 °¡ ÇÃÄ£Ãß°¡ ±¹½Ã¿ø, Á¦5ȸ ¾à»ç¿¹ºñ½ÃÇè ÇÕ°ÝÀÚ¹ßÇ¥ 179¸í ÀÀ½ÃÇØ 83¸í ÇÕ°Ý...À۳⠴ëºñ ÇÕ°Ý·ü 20% »ó½Â [µ¥Àϸ®ÆÊ=Á¤ÈïÁØ ±âÀÚ] ÇØ¿Ü ¾à´ë Ãâ½Å 83¸íÀÌ ³»³â ¾à»ç±¹°¡°í½Ã ÀÀ½Ã ÀÚ°ÝÀ» ¾ò¾ú´Ù. ±¹½Ã¿øÀÌ ¿À´Ã(4ÀÏ) °øÁöÇÑ Á¦5ȸ ¾à»ç¿¹ºñ½ÃÇè °á°ú¿¡ µû¸£¸é ÇÕ°ÝÀÚ´Â ÀÀ½ÃÀÚ 179¸í Áß 83¸í·Î 46.4%ÀÇ ÇÕ°Ý·üÀÌ´Ù. ¡ãÇØ¿Ü¾à´ë Ãâ½Å 179¸í Áß 83¸íÀÌ ÇÕ°ÝÇß´Ù. ÇÕ°Ý·üÀº 46.4%´Ù. ¸Å³â ¿Ï¸¸ÇÏ°Ô »ó½ÂÇÏ´ø ÇÕ°Ý·üÀº ¿ÃÇØ ±ÞÁõÇß´Ù. 1ȸ ¿¹ºñ½ÃÇè¿¡¼ 5.8%¿´´ø ÇÕ°Ý·üÀº ¼¼È÷ »ó½ÂÇØ ÀÛ³â 4ȸ ½ÃÇè¿¡¼´Â 27.2%¸¦ ±â·ÏÇß´Ù. ¿ÃÇØ ÀÀ½ÃÀÚ°¡ ´Ã¾î³µ°í, ÇÕ°Ý·üÀº À۳⠴ëºñ ¾à 20% °¡±îÀÌ »ó½ÂÇÏ¸é¼ ÇÕ°Ý»ýÀÌ ´ë°Å ´Ã¾ú´Ù. ¸Å³â ¾à»ç¿¹ºñ½ÃÇè ÇÕ°ÝÀÚ Áß ±Ø¼Ò¼ö¸¦ Á¦¿ÜÇϰí´Â ¾à»ç±¹½Ã¿¡ ÇÕ°ÝÇÏ´Â Ãß¼¼´Ù. 1~3ȸÂ÷¿¡¼´Â 1¸íÀ» Á¦¿ÜÇϰí´Â ±¹½Ã ÇÕ°ÝÇß´Ù. X AD ·Î°ÔÀÎÆû ¸ð¸àÅ͸® À̺¥Æ®Âü¿© ¡æ Á¤ÈïÁØ ±âÀÚ(jhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °ü·Ã±â»ç · ÇØ¿Ü¾à´ë Ãâ½Å ¾à»ç ´õ ´Ã¾î³´Ù...¿¹ºñ½ÃÇè 196¸í... · ±Þ°¨Çß´ø ÇØ¿Ü¾à´ë Ãâ½Å ¾à»ç, 4³â »õ 8¹è Áõ°¡ · Çʸ®ÇÉÀº ÀÌÁ¨ ¿¾¸»...¿Ü±¹ ¾à´ë ±¹½ÃÇÕ°Ý ¹Ì±¹ÀÌ ... ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â °æ·ÂÁ÷ MRä¿ë (¼öµµ±Ç) ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â 2025³â »ó¹Ý±â ¼ö½Ãä¿ë(ÇмúÀÇÇнÇ, BDÆÀ ¾à»ç) ¹Ù·Î°¡±â RA, PMS, MSL ,PM, MR, MM µî °¢ ºÎ¹® ¸ðÁý ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â Sr. RA Specialist & RA Specialist (2 Year Contract) ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â [Çѵ¶] Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®, MA, Ãѹ« ÆÀÀå, Á¦Á¶°ü¸® ¾à»ç, ÀÌÈÇнÃÇè(QC), ±â¼úÆÀ ±³Á¤´ã´ç, Àü¹®ÀǾàǰ ¸¶ÄÉÆÃ, ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÇØ¿Ü¾à´ë Ãâ½Å 83¸í, ¾à»ç±¹½Ã º»´Ù...¿¹ºñ½ÃÇè ÇÕ°Ý·ü 46% URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÇØ¿Ü¾à´ë Ãâ½Å 83¸í, ¾à»ç±¹½Ã º»´Ù...¿¹ºñ½ÃÇè ÇÕ°Ý·ü 46% ±â»çÀÔ·Â : 24.07.04 14:15:02 0 °¡ ÇÃÄ£Ãß°¡ ±¹½Ã¿ø, Á¦5ȸ ¾à»ç¿¹ºñ½ÃÇè ÇÕ°ÝÀÚ¹ßÇ¥ 179¸í ÀÀ½ÃÇØ 83¸í ÇÕ°Ý...À۳⠴ëºñ ÇÕ°Ý·ü 20% »ó½Â [µ¥Àϸ®ÆÊ=Á¤ÈïÁØ ±âÀÚ] ÇØ¿Ü ¾à´ë Ãâ½Å 83¸íÀÌ ³»³â ¾à»ç±¹°¡°í½Ã ÀÀ½Ã ÀÚ°ÝÀ» ¾ò¾ú´Ù. ±¹½Ã¿øÀÌ ¿À´Ã(4ÀÏ) °øÁöÇÑ Á¦5ȸ ¾à»ç¿¹ºñ½ÃÇè °á°ú¿¡ µû¸£¸é ÇÕ°ÝÀÚ´Â ÀÀ½ÃÀÚ 179¸í Áß 83¸í·Î 46.4%ÀÇ ÇÕ°Ý·üÀÌ´Ù. ¡ãÇØ¿Ü¾à´ë Ãâ½Å 179¸í Áß 83¸íÀÌ ÇÕ°ÝÇß´Ù. ÇÕ°Ý·üÀº 46.4%´Ù. ¸Å³â ¿Ï¸¸ÇÏ°Ô »ó½ÂÇÏ´ø ÇÕ°Ý·üÀº ¿ÃÇØ ±ÞÁõÇß´Ù. 1ȸ ¿¹ºñ½ÃÇè¿¡¼ 5.8%¿´´ø ÇÕ°Ý·üÀº ¼¼È÷ »ó½ÂÇØ ÀÛ³â 4ȸ ½ÃÇè¿¡¼´Â 27.2%¸¦ ±â·ÏÇß´Ù. ¿ÃÇØ ÀÀ½ÃÀÚ°¡ ´Ã¾î³µ°í, ÇÕ°Ý·üÀº À۳⠴ëºñ ¾à 20% °¡±îÀÌ »ó½ÂÇÏ¸é¼ ÇÕ°Ý»ýÀÌ ´ë°Å ´Ã¾ú´Ù. ¸Å³â ¾à»ç¿¹ºñ½ÃÇè ÇÕ°ÝÀÚ Áß ±Ø¼Ò¼ö¸¦ Á¦¿ÜÇϰí´Â ¾à»ç±¹½Ã¿¡ ÇÕ°ÝÇÏ´Â Ãß¼¼´Ù. 1~3ȸÂ÷¿¡¼´Â 1¸íÀ» Á¦¿ÜÇϰí´Â ±¹½Ã ÇÕ°ÝÇß´Ù. X AD ·Î°ÔÀÎÆû ¸ð¸àÅ͸® À̺¥Æ®Âü¿© ¡æ Á¤ÈïÁØ ±âÀÚ(jhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °ü·Ã±â»ç · ÇØ¿Ü¾à´ë Ãâ½Å ¾à»ç ´õ ´Ã¾î³´Ù...¿¹ºñ½ÃÇè 196¸í... · ±Þ°¨Çß´ø ÇØ¿Ü¾à´ë Ãâ½Å ¾à»ç, 4³â »õ 8¹è Áõ°¡ · Çʸ®ÇÉÀº ÀÌÁ¨ ¿¾¸»...¿Ü±¹ ¾à´ë ±¹½ÃÇÕ°Ý ¹Ì±¹ÀÌ ... ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â °æ·ÂÁ÷ MRä¿ë (¼öµµ±Ç) ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â 2025³â »ó¹Ý±â ¼ö½Ãä¿ë(ÇмúÀÇÇнÇ, BDÆÀ ¾à»ç) ¹Ù·Î°¡±â RA, PMS, MSL ,PM, MR, MM µî °¢ ºÎ¹® ¸ðÁý ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â Sr. RA Specialist & RA Specialist (2 Year Contract) ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â [Çѵ¶] Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®, MA, Ãѹ« ÆÀÀå, Á¦Á¶°ü¸® ¾à»ç, ÀÌÈÇнÃÇè(QC), ±â¼úÆÀ ±³Á¤´ã´ç, Àü¹®ÀǾàǰ ¸¶ÄÉÆÃ, ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÇØ¿Ü¾à´ë Ãâ½Å 83¸í, ¾à»ç±¹½Ã º»´Ù...¿¹ºñ½ÃÇè ÇÕ°Ý·ü 46% URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÇØ¿Ü¾à´ë Ãâ½Å 83¸í, ¾à»ç±¹½Ã º»´Ù...¿¹ºñ½ÃÇè ÇÕ°Ý·ü 46% ±â»çÀÔ·Â : 24.07.04 14:15:02 0 °¡ ÇÃÄ£Ãß°¡ ±¹½Ã¿ø, Á¦5ȸ ¾à»ç¿¹ºñ½ÃÇè ÇÕ°ÝÀÚ¹ßÇ¥ 179¸í ÀÀ½ÃÇØ 83¸í ÇÕ°Ý...À۳⠴ëºñ ÇÕ°Ý·ü 20% »ó½Â [µ¥Àϸ®ÆÊ=Á¤ÈïÁØ ±âÀÚ] ÇØ¿Ü ¾à´ë Ãâ½Å 83¸íÀÌ ³»³â ¾à»ç±¹°¡°í½Ã ÀÀ½Ã ÀÚ°ÝÀ» ¾ò¾ú´Ù. ±¹½Ã¿øÀÌ ¿À´Ã(4ÀÏ) °øÁöÇÑ Á¦5ȸ ¾à»ç¿¹ºñ½ÃÇè °á°ú¿¡ µû¸£¸é ÇÕ°ÝÀÚ´Â ÀÀ½ÃÀÚ 179¸í Áß 83¸í·Î 46.4%ÀÇ ÇÕ°Ý·üÀÌ´Ù. ¡ãÇØ¿Ü¾à´ë Ãâ½Å 179¸í Áß 83¸íÀÌ ÇÕ°ÝÇß´Ù. ÇÕ°Ý·üÀº 46.4%´Ù. ¸Å³â ¿Ï¸¸ÇÏ°Ô »ó½ÂÇÏ´ø ÇÕ°Ý·üÀº ¿ÃÇØ ±ÞÁõÇß´Ù. 1ȸ ¿¹ºñ½ÃÇè¿¡¼ 5.8%¿´´ø ÇÕ°Ý·üÀº ¼¼È÷ »ó½ÂÇØ ÀÛ³â 4ȸ ½ÃÇè¿¡¼´Â 27.2%¸¦ ±â·ÏÇß´Ù. ¿ÃÇØ ÀÀ½ÃÀÚ°¡ ´Ã¾î³µ°í, ÇÕ°Ý·üÀº À۳⠴ëºñ ¾à 20% °¡±îÀÌ »ó½ÂÇÏ¸é¼ ÇÕ°Ý»ýÀÌ ´ë°Å ´Ã¾ú´Ù. ¸Å³â ¾à»ç¿¹ºñ½ÃÇè ÇÕ°ÝÀÚ Áß ±Ø¼Ò¼ö¸¦ Á¦¿ÜÇϰí´Â ¾à»ç±¹½Ã¿¡ ÇÕ°ÝÇÏ´Â Ãß¼¼´Ù. 1~3ȸÂ÷¿¡¼´Â 1¸íÀ» Á¦¿ÜÇϰí´Â ±¹½Ã ÇÕ°ÝÇß´Ù. X AD ·Î°ÔÀÎÆû ¸ð¸àÅ͸® À̺¥Æ®Âü¿© ¡æ Á¤ÈïÁØ ±âÀÚ(jhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
°ü·Ã±â»ç · ÇØ¿Ü¾à´ë Ãâ½Å ¾à»ç ´õ ´Ã¾î³´Ù...¿¹ºñ½ÃÇè 196¸í... · ±Þ°¨Çß´ø ÇØ¿Ü¾à´ë Ãâ½Å ¾à»ç, 4³â »õ 8¹è Áõ°¡ · Çʸ®ÇÉÀº ÀÌÁ¨ ¿¾¸»...¿Ü±¹ ¾à´ë ±¹½ÃÇÕ°Ý ¹Ì±¹ÀÌ ...
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÇØ¿Ü¾à´ë Ãâ½Å 83¸í, ¾à»ç±¹½Ã º»´Ù...¿¹ºñ½ÃÇè ÇÕ°Ý·ü 46% URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö